Emily Noël

Dr. Emily Noël

Department of Biomedical Science, University of Sheffield, United Kingdom
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Cell
Verified
Journal Article
Closed access
JJJan Philipp Junker
Jan Philipp Junker
Emily NoëlEmily Noël
Emily Noël
VGVictor Guryev
Victor Guryev
KPKevin A. Peterson
Kevin A. Peterson
GSGopi Shah
Gopi Shah
AOAlexander van Oudenaarden
Alexander van Oudenaarden

1 January 2016 in Developmental Cell
Verified
Journal Article
Closed access
CWChi-Chung Wu
Chi-Chung Wu
FKFabian Kruse
Fabian Kruse
MVMohankrishna Dalvoy Vasudevarao
Mohankrishna Dalvoy Vasudevarao
JJJan Philipp Junker
Jan Philipp Junker
DZDavid C. Zebrowski
David C. Zebrowski
Jeroen BakkersJeroen Bakkers
Jeroen Bakkers

31 March 2021 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
GBGeorge Bowley
George Bowley
EKElisabeth Kugler
Elisabeth Kugler
RWRob Wilkinson
Rob Wilkinson
ALAllan Lawrie
Allan Lawrie
FEFreek van Eeden
Freek van Eeden
JSJovana Serbanovic‐Canic
Jovana Serbanovic‐Canic
Mammalian models including non‐human primates, pigs and rodents have been used extensively to study the mechanisms of cardiovascular disease. However, there is an increasing desire for alternative model systems that provide excellent scientific value while replacing or reducing the use of mammals. Here, we review the use of zebrafish, Danio rerio, to study cardiovascular development and disease. The anatomy and physiology of zebrafish and mammalian cardiovascular systems are compared, and we describe the use of zebrafish models in studying the mechanisms of cardiac (e.g. congenital heart defects, cardiomyopathy, conduction disorders and regeneration) and vascular (endothelial dysfunction and atherosclerosis, lipid metabolism, vascular ageing, neurovascular physiology and stroke) pathologies. We also review the use of zebrafish for studying pharmacological responses to cardiovascular drugs and describe several features of zebrafish that make them a compelling model for in vivo screening of compounds for the treatment cardiovascular disease.LINKED ARTICLES: This article is part of a themed issue on Preclinical Models for Cardiovascular disease research (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.5/issuetoc

11 November 2013 in Nature Communications
Verified
Journal Article
Closed access
PDF file
Emily NoëlEmily Noël
Emily Noël
MVManon Verhoeven
Manon Verhoeven
ALAnne Karine Lagendijk
Anne Karine Lagendijk
FTFederico Tessadori
Federico Tessadori
Kelly SmithKelly Smith
Kelly Smith
Jeroen BakkersJeroen Bakkers
Jeroen Bakkers

1 October 2008 in Developmental Biology
Verified
Journal Article
Open access
Emily NoëlEmily Noël
Emily Noël
ACAntonio Casal-Sueiro
Antonio Casal-Sueiro
EBElisabeth Busch-Nentwich
Elisabeth Busch-Nentwich
HVHeather Verkade
Heather Verkade
PDP. Duc Si Dong
P. Duc Si Dong
EOElke A. Ober
Elke A. Ober
Liver, pancreas and lung originate from the presumptive foregut in temporal and spatial proximity. This requires precisely orchestrated transcriptional activation and repression of organ-specific gene expression within the same cell. Here, we show distinct roles for the chromatin remodelling factor and transcriptional repressor Histone deacetylase 1 (Hdac1) in endodermal organogenesis in zebrafish. Loss of Hdac1 causes defects in timely liver specification and in subsequent differentiation. Mosaic analyses reveal a cell-autonomous requirement for hdac1 within the hepatic endoderm. Our studies further reveal specific functions for Hdac1 in pancreas development. Loss of hdac1 causes the formation of ectopic endocrine clusters anteriorly to the main islet, as well as defects in exocrine pancreas specification and differentiation. In addition, we observe defects in extrahepatopancreatic duct formation and morphogenesis. Finally, loss of hdac1 results in an expansion of the foregut endoderm in the domain from which the liver and pancreas originate. Our genetic studies demonstrate that Hdac1 is crucial for regulating distinct steps in endodermal organogenesis. This suggests a model in which Hdac1 may directly or indirectly restrict foregut fates while promoting hepatic and exocrine pancreatic specification and differentiation, as well as pancreatic endocrine islet morphogenesis. These findings establish zebrafish as a tractable system to investigate chromatin remodelling factor functions in controlling gene expression programmes in vertebrate endodermal organogenesis.

1 March 2021 in Development
Verified
Journal Article
Open access
PDF file
CDChristopher J. Derrick
Christopher J. Derrick
Emily NoëlEmily Noël
Emily Noël
The developing heart is formed of two tissue layers separated by an extracellular matrix (ECM) that provides chemical and physical signals to cardiac cells. While deposition of specific ECM components creates matrix diversity, the cardiac ECM is also dynamic, with modification and degradation playing important roles in ECM maturation and function. In this Review, we discuss the spatiotemporal changes in ECM composition during cardiac development that support distinct aspects of heart morphogenesis. We highlight conserved requirements for specific ECM components in human cardiac development, and discuss emerging evidence of a central role for the ECM in promoting heart regeneration.